[1]
Theodosakis, N. 2018. Inhibition of isoprenoid synthesis synergizes with MAPK blockade to prevent growth in targeted therapy-resistant melanoma. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S114-S115. DOI:https://doi.org/10.25251/skin.2.supp.104.